Biweekly Docetaxel and Vinorelbine as First-Line Chemotherapy in Metastatic Breast Cancer von Mayordomo, Jose I., Millá, Alfredo, Morales, Serafín, Yubero, Alfonso, Lorenzo, Antonio, Baena, José M., Modolell, Alfonso, Sanz, Javier, Illarramendi, Jose, García, María J., Machengs, Ignacio, Burillo, Miguel A., Tres, Alejandro

Volltext

Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study von MORALES, Serafin, LORENZO, Antonio, OLTRA, Amparo, FRAU, Adolfo, MACHENGS, Ignacio, GALAN, Antonio, BELON, Joaquin, LLORCA, Cristina, RAMOS, Manuel, BALLESTEROS, Pedro, MENDEZ, Miguel, ALMANZA, Concepcion, CASTELLANOS, Javier, MORENO-NOGUEIRA, José Andrés, CASAL, Joaquin, LIZON, José

Volltext

Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study von Morales Serafín, Lorenzo, Antonio, Ramos, Manuel, Ballesteros, Pedro, Méndez, Miguel, Almanza Concepción, Castellanos, Javier, Moreno-Nogueira, José Andrés, Casal Joaquín, Lizón José, Oltra Amparo, Frau Adolfo, Machengs Ignacio, Galán, Antonio, Belón Joaquín, Llorca Cristina

Volltext